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Abstract: Circular RNAs and microRNAs widely exist in various species and play crucial roles in
multiple biological processes. It is essential to study their roles in myogenesis. In our previous
sequencing data, both miR-30a-3p and circular HIPK3 (circHIPK3) RNA, which are produced by
the third exon of the HIPK3 gene, were differentially expressed among chicken skeletal muscles
at 11 embryo age (E11), 16 embryo age (E16), and 1-day post-hatch (P1). Here, we investigated
their potential roles in myogenesis. Proliferation experiment showed that miR-30a-3p could inhibit
the proliferation of myoblast. Through dual-luciferase assay and Myosin heavy chain (MYHC)
immunofluorescence, we found that miR-30a-3p could inhibit the differentiation of myoblast by
binding to Myocyte Enhancer Factor 2 C (MEF2C), which could promote the differentiation of
myoblast. Then, we found that circHIPK3 could act as a sponge of miR-30a-3p and exerted a
counteractive effect of miR-30a-3p by promoting the proliferation and differentiation of myoblasts.
Taking together, our data suggested that circHIPK3 could promote the chicken embryonic skeletal
muscle development by sponging miR-30a-3p.
Keywords: circular RNA; circHIPK3; microRNA; miR-30a-3p; skeletal muscle; proliferation;
differentiation

1. Introduction
Skeletal muscles are important components in animals. Chicken skeletal muscle, which can
provide high quality protein, is one of the most important meat source for humans. The development
of skeletal muscle is regulated by multiple factors, including genetics, nutrition, disease, environment
and so on [1,2]. Heritability estimates showed that chicken growth could be enhanced by genetic
improvement [3]. The genetic factors which control skeletal muscle development include genes and
non-coding RNAs.
MicroRNAs (miRNAs) have been shown to be involved in many biological processes, including
muscle development [4]. Some myogenic miRNAs, including the miR-1 family, miR-206 and miR-133
family, regulate muscle development by targeting and inhibiting the expression of muscle-related
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gene [5,6]. Previous studies in our group showed that miR-203, miR-16, miR-29, and miR-1611 all
played crucial roles in myoblast proliferation and differentiation [7–10]. Two other studies found
that miR-30a-3p could suppress tumor growth [11,12]. However, the molecular function of chicken
miR-30a-3p has not yet been reported.
Circular RNAs, which widely exist in the transcriptomes of different species and tissues, were
previously considered as a kind of non-coding RNA, but they have now been demonstrated to have
both coding and regulating functions [13–15]. Circular RNA, formed by the covalently joined 50 and 30
ends of linear RNA, possess a more stable structure than linear RNA. The functions of circular RNA
include, acting as a miRNA sponge, participating in regulating the expression of its own linear RNA in
different ways, coding protein, and deriving pseudogenes [16,17]. Previous studies found that circular
RNAs were abundantly expressed in skeletal muscle tissue in many species [14,18,19]. Circular RNAs in
chicken skeletal muscle could act as an miRNA sponge and regulate chicken muscle development [19].
A circular RNA, produced by SVIL could promote the proliferation and differentiation of myoblast
cells by sponging miR-203 [20]. Circular RNA circFGFR2, generated by the FGFR2 gene, could interact
with miR-133a-5p and miR-29b-1-5p to regulate myoblast cells development [7].
A circular RNA produced by the third exon of the chicken HIPK3 gene (circHIPK3—01, we named
it as circHIPK3, hereinafter) has the highest expression level compare to other circular RNAs generated
from HIPK3 gene. It was also differentially expressed in different stages of skeletal development.
We predicted it has three potential binding sites for miR-30a-3p. In this study, we aimed to
examine the interaction of circHIPK3 and miR-30a-3p and their functions on myoblast proliferation
and differentiation.
2. Materials and Methods
2.1. Ethics Statement
All animal experiments performed in this study met the requirements of the Institutional Animal
Care and Use Committee at the South China Agricultural University (approval ID: SCAU#0014).
All efforts were made to minimize the suffering of animals.
2.2. Primers
All primers that were used in this study were synthesized by Sangon (Sangon Biotech, Shanghai,
China). The primers listed in Table 1 were designed by Premier Primer 5.0 software (Premier Bio-soft
International, Palo Alto, CA, USA). Information of the qRT-PCR primers for MYOD, MYOG, MYHC
and GAPDH were shown in our previous study [21].
2.3. Cell Culture and Transfection
Chicken primary myoblasts (CPMs) were isolated from the leg muscle of 10-day Yuhe chicken
embryos (E10; Zhuhai Yuhe Company Ltd., Zhuhai, China), as described in our previous study [7].
Briefly, the legs of E10 chickens were collected, and the skin and bones were removed. Then, leg
muscles were minced with scissors and trypsinized (Gibco, Grand Island, NY, USA) at 37 ◦ C for
20 min). Digestion was done with complete 1640 medium-(RPMI), containing 20% fetal bovine serum
(FBS), 1% nonessential amino acids, and 0.2% penicillin/streptomycin (Invitrogen, Carlsbad, CA,
USA). The mixture was filtered and centrifuged at 500 g for 5 min. Following the serial plating, the
cells were cultured in complete medium and incubated at 37 ◦ C, in a 5% CO2 humidified atmosphere.
Chicken fibroblast DF-1 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) (Gibco,
Grand Island, NY, USA) supplemented with 10% FBS and 0.2% penicillin/streptomycin (Invitrogen,
Carlsbad, CA, USA), then incubated with 5% CO2 at 37 ◦ C humidity. DNA plasmids, miRNA mimic,
mimic negative control (mimic NC), miRNA inhibitors, inhibitor negative control (inhibitor NC), small
interfering RNA (siRNA), and siRNA negative control (siRNA NC) were transiently transfected into
cells using Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA, USA).

Cells 2019, 8, 177

3 of 19

2.4. RNA Exaction, cDNA Synthesis and Quantitative Real-Time PCR (qRT-PCR)
All RNAs were exacted using Trizol reagent (TaKaRa, Otsu, Japan) according to the manufacturer’s
instructions. The quality and concentrations of the RNA samples were detected by 1.5% agarose gel
electrophoresis. Total RNA was employed to synthesize cDNA, using a Primescript RT Reagent Kit
with gDNA Eraser (Perfect Real Time) (TaKaRa, Otsu, Japan). Synthesized cDNA libraries were diluted
with RNase-free water at a ratio of 1:3 before real-time PCR. Relative mRNA expression levels were
detected by qRT-PCR using SsoFast Eva Green Supermix (Bio-Rad, Hercules, CA, USA). GAPDH was
used as an internal control. Reverse transcription for miRNA was conducted using ReverTra Ace qPCR
RT Kit (Toyobo, Osaka, Japan). The specific bulge-loop miRNA qRT-PCR primer for miR-30a-3p and
U6 were designed by RiboBio (RiboBio, Guangzhou, China). All qRT-PCR reactions were conducted
with a CFX96 system (Bio-Rad, Hercules, CA, USA). All reactions were run in triplicates and fold
expression changes were calculated using the comparative 2–∆∆Ct method.
2.5. Validation of circHIPK3
Based on the NCBI reference sequences of HIPK3 (NCBI accession number: NM_001199411.1),
convergent and divergent primers were designed to validate the existence of circHIPK3. To confirm the
cirHIPK3 junction, genomic DNA, and cDNA from CPMs were used for PCR reaction. All PCR
products were sequenced by Sangon Biotech Co Ltd. Sequence analysis was conducted using
DNASTAR software (DNASTAR 7.1, http://www.dnastar.com). For RNase R treatment, 2 mg of
total RNA was incubated 20 min at 37 ◦ C with RNase R (Epicentre Technologies, Madison, WI, USA),
and employed to synthesize cDNA for qPCR. For the control group, the same amount of RNA was
incubated 20 min at 37 ◦ C and subsequently used to synthesize cDNA.
2.6. Plasmids Construction and RNA Oligonucleotides
For the construction of the circHIPK3 over-expression vector, exon 3 of HIPK3 was amplified
using cDNA, produced from CPMs and cloned into a pCD5ciR vector (Geneseed Biotech, Guangzhou,
China) between EcoRI and BamHI restriction sites. The siRNAs to circHIPK3, which especially
target the circHIPK3 rather than the linear HIPK3, were designed and synthesized by Geneseed
using the sequence shown in Table 1. The gga-miR-30a-3p mimic, mimic NC, the gga-miR-30a-3p
inhibitor and inhibitor NC were synthesized by RiboBio (Guangzhou, China). For the construction of
pmirGLO Dual-Luciferase reporter vector, wild-type and mutated sequences in the 30 UTR region of
MEF2C and the partial region of circHIPK3, which include the predicted binding sites of miR-30a-3p,
were synthesized and inserted into pmirGLO vectors (Promega, Madison, WI, USA), according to
instructions, using NheI and XhoI restriction sites. The gga-miR-30a sequence was also synthesized
and inserted into pmirGLO vectors.
2.7. 5-Ethynyl-20 -Deoxyuridine (EdU) Assay
After 48 h of transfection, the treated CPMs and negative control groups in 24-well plates
were incubated with 50 µM 5-ethynyl-20-deoxyuridine (RiboBio, Guangzhou, China) for 2 h at
37 ◦ C. After washing twice, the cells were stained with C10310 EdU Apollo. EdU-stained cells were
counted using a Leica DMi8 fluorescent microscope (400× magnification) (Leica, Wetzlar, Germany).
The ratio of EDU-stained cells to Hoechst 33342-stained cells was calculated and represented the CPM
proliferation rate. Detailed protocols were described in the manufacturer0 s instruction.
2.8. Flow Cytometry of the Cell Cycle
After 48 h of transient transfection with the over-expression plasmid (blank vector) and siRNA
(siRNA NC), CPMs were collected from the 12-well plates and kept overnight in 70% ethanol at
−20 ◦ C. The cells were then incubated with 50 µg/mL PI (propidium iodide) (Sigma, Louis, MO, USA),
10 µg/mL RNase A (Takara, Otsu, Japan) and 0.2% (v/v) Triton X-100 (Sigma, Louis, MO, USA) at 4 ◦ C
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for 30 min. Lastly, cells were detected with a BD AccuriC6 flow cytometer (BD Biosciences, San Jose,
CA, USA), and the results were analyzed by FlowJo7.6 software.
2.9. Cell Counting Kit 8 (CCK-8) Assay
CPMs were seeded in a 48-well plate and cultured in complete medium. After transfection, cell
proliferation was detected at 12, 24, 36, and 48 h using the TransDetect CCK Kit (TransGen Biotech,
Beijing, China), following the manufacturer’s protocol. Cells were added in 25 uL CCK solution to each
well and incubated for 2 h at 37 ◦ C in a 5% CO2 cell incubator. Then absorbance of treated and control
groups were measured with a Fluorescence/Multi-Detection Microplate Reader (BioTek, Winooski,
VT, USA) by optical density at a wavelength of 450 nm.
2.10. Immunofluorescence
For immunofluorescence, after transfection, cells in 12-well plates were fixed for 30 min with 4%
formaldehyde. Cells were then permeabilized by adding 0.1% Triton X-100 for 5 min and blocked for
30 min with goat serum. Following overnight incubation at 4 ◦ C with anti-MYHC (B103; DHSB, Iowa
City, IA, USA; 0.5 µg/mL), Fluorescein (FITC)-conjugated AffiniPure Goat Anti-Mouse IgG (H + L)
(Bioworld, Minneapolis, MN, USA; 1:200) was added to the plate and incubated at room temperature
for 1 h. Cell nuclei were stained with DAPI (1:50, Beyotime, Shanghai, China) for 5 min. The images
were captured with fluorescence microscopy (Leica, Wetzlar, Germany). The area of cells labeled with
anti-MYHC was measured using Photoshop software (Adobe Photoshop CC 2018, Adobe, San Jose,
CA, USA), and the total myotube area was calculated as a percentage of the total image area covered
by myotubes.
2.11. Binding Relationship Prediction and Dual-Luciferase Reporter Assay
To predict the relationship between target genes and miR-30a-3p, miRDB (http://mirdb.org/
miRDB/) and RNAhybrid (http://bibiserv2.cebitec.uni-bielefeld.de/rnahybrid) were employed.
After seeding DF-1 cells in the 96-well plate and culturing for 24 h, four groups (wild type pmirGLO
plasmids and mimic as the treatment, mutated pmirGLO plasmids and mimic, wild type pmirGLO
plasmids and mimic NC, mutated type pmirGLO plasmids and mimic NC) were set and co-transfected.
For the confirmation of the target relationship between circHIPK3 and miR-30a-3p, another method
of Dual-Luciferase reporter assay was employed. Three groups (circHIPK3 over-expression plasmid
and miR-30a-3p mimic, pCD5ciR and miR-30a-3p mimic, pCD5ciR and mimic NC) were set and
co-transfected with a pmirGLO vector containing the miR-30a sequence. After 48 h, Dual-GLO
Luciferase Assay System kit (Promega, Madison, WI, USA) was employed to detect luminescent
signals of firefly and Renilla Luciferase with a Fluorescence/Multi-Detection Microplate Reader
(BioTek, Winooski, VT, USA). Firefly luciferase activities were normalized to Renilla luminescence in
each well. Detailed protocols were described in the manufacturer’s instruction.
2.12. Western Blotting
Briefly, cells were lysed in the radio immune precipitation assay (RIPA) buffer (Beyotime, Shanghai,
China) containing phenylmethane sulfonyl fluoride (PMSF) protease inhibitor (Beyotime, Shanghai,
China). After incubation on ice for 30 min, the samples were centrifuged at 10,000 g for 10 min at
4 ◦ C, and the supernatant was collected. Proteins were separated by SDS-PAGE and blotted onto
nitrocellulose membranes (Whatman, Maidstone, UK), then membranes were probed with primary and
secondary antibodies. The primary antibodies used were anti-MYHC (1:1000, B103; DHSB, Iowa City,
IA, USA), anti-GAPDH (1:1500, AB-P-R 001, Hangzhou Goodhere Biotech, Hangzhou, China), and
anti-Tubulin (1:1000, Beyotime, Shanghai, China). The secondary antibodies used were goat anti-rabbit
IgG-HRP (1:5000, BA1054, Boster, Wuhan, China) and peroxidase-goat anti-mouse IgG (1:2500, BA1051,
Boster, Wuhan, China). Image J software (d1.47, National Institutes of Health, Bethesda, MD, USA)
was used to quantify the band intensity.
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2.13. Statistical Analysis
All results were presented as a mean ± SEM and were subjected to statistical analysis by two-tailed
t-test. The level of significance was presented as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001).
Table 1. Primers and RNA oligos used in this study.
Nucleotide Sequences (50 →30 )

Name
QcircHIPK3
QHIPK3
QMEF2C
Convergent
primers
Divergent primers

F: GTTTAATCCACGCTGACCTCA
R: GACTTGTGAGGCCATACCTATA
F: GGGGTATGTCCCGGAG
R: CTTCGCTAATGGAACAACAC
F: AGGGTGTATGTGCAGGAACG
R: AGCAATCTCGCAGTCACACA
F: TGGTACAAGCGGAGATGG
R: TTGAGGTCAGCGTGGATTA
F: GCACGCCAAGGACAAATA

Tm. (◦ C)

Product Size (bp)

Application

61.3

130

qPCR for circHIPK3

61.3

261

qPCR for HIPK3

60

288

qPCR for MEF2C

55

450

Amplification of partial
sequence of exon 3 of HIPK3

58

782

52–65

179

qPCR forβ-actin

-

-

-

R: TACGCTTCAATCCACATCG
β-actin
si-circHIPK3-001
si-circHIPK3-002
si-circHIPK3-003

F: CTCCCCCATGCCATCCTCCGTCTG
R: GCTGTGGCCATCTCCTGCTC
CCCGGTATTATAGGTATGG
GGTATTATAGGTATGGCCT
ATTATAGGTATGGCCTCAC

Amplification of partial
sequence of circHIPK3
which contain the joint site

Note: The nucleotide sequences of si-circHIPK3 represent the target sequences of each siRNA.

3. Results
3.1. circHIPK3 Differentially Expressed during Embryonic Leg Muscle Development
Previous circular RNA sequencing data from our lab revealed 11 circular RNAs were generated
by the HIPK3 gene (available in the Gene Expression Omnibus with accession number GSE89355).
The genomic structure of chicken HIPK3 and the regions, in which all the circular HIPK3 (circHIPK3)
RNA were derived, are shown in Figure 1A. Interestingly, circHIPK3 (referred as circHIPK3—01 in
Figure 1A), which was derived from exon3 of HIPK3, was the only exonic circular RNA. Compared with
other circular RNAs derived from HIPK3, circHIPK3 had the highest expression level. Its expression
level in E16 was significantly higher than in E11 and P1 (Figure 1B). The expression levels of circHIPK3
and HIPK3 mRNA in E11, E12, E16, and E18 were detected by qRT-PCR (Figure 1C). The trend of the
expression level of circHIPK3 was consistent with the result from the sequencing data. However, the
expression patterns of circHIPK3 and HIPK3 mRNA were not identical, which indicated that they
might have different functions during leg muscle development. To confirm the sequence and the
junction of circHIPK3, genomic DNA and cDNA were used for the PCR reaction, with convergent and
divergent primers. The result of the PCR product electrophoresis showed the expectants of convergent
primers were amplified with both templates. However, there was no PCR product of divergent primers
with the genomic DNA template (Figure 1D). PCR products of divergent primers were analyzed by
Sanger sequencing (Figure 1E). Sequencing results showed that circHIPK3 was generated from the
third exon of HIPK3. The circHIPK3 was also validated by RNase R digestion. The result of qRT-PCR
showed that RNase R had no impact on circHIPK3, whereas the levels of linear RNA, HIPK3 and
β-actin, were significantly decreased (Figure 1F). These results validated the existence and differential
expression of circHIPK3 during skeletal muscle development of chicken.
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(D) Divergent primers amplified circHIPK3 in cDNA but not genomic DNA (gDNA). White triangles
represent convergent primers and black triangles represent divergent primers. (E) Sanger sequencing
confirmed the junction sequence of circHIPK3. (F) Quantitative real-time PCR (qRT-PCR) showed the
resistance of circHIPK3 to RNase R digestion. In all panels, values represent mean ± SEM from three
independent experiments. * p < 0.05; ** p < 0.01; *** p < 0.001.
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3.2. circHIPK3 Interacts with miR-30a-3p
Many studies showed that circular RNAs exerted their functions by acting as the miRNA sponge.
CircHIPK3 was predicted by miRDB and RNAhybrid to be a target of multiple miRNAs. Among these
miRNAs, ggs-miR-30a-3p was chosen as a candidate because there were three potential binding sites
in circHIPK3 (Figure 2A). The seed sequence of miR-30a-3p matched with three sites in circHIPK3
(Figure 2B). Besides, the prediction results from RNAhybrid indicated that the binding site 2 was the
most stable format (Figure 2C). To identify the interactions between circHIPK3 and miR-30a-3p, the
over-expression vector of circHIPK3 was constructed and transfected into DF-1 cells. The expression
efficiency of the over-expression vector was detected by qPCR. Compared with the group transfected
with pCD5ciR, the circHIPK3 over-expression vector expressed a higher level of circHIPK3 (Figure 2D).
Then, circHIPK3 over-expression vector and miR-30a-3p mimic were co-transfected into DF-1 cells with
a pmirGLO vector, containing the miR-30a sequence. Meanwhile, as the control group, the pCD5ciR
and miR-30a-3p mimic (or mimic NC) were co-transfected with the pmirGLO vector, containing the
miR-30a sequence. The results showed that the relative luminescence activity of the group with
circHIPK3 over-expression vector and miR-30a-3p mimic was significantly higher than the group
with pCD5ciR and miR-30a-3p mimic, but had no difference compared with the group pCD5ciR
and mimic NC (Figure 2E). These results suggest that circHIPK3 could bind with miR-30a-3p mimic.
In addition, sequences which contained binding site 2 or the mutated sequence were inserted into
pmirGLO vector. Recombinant vectors with the wild type sequence was then co-transfected into DF-1
cells with miR-30a-3p mimic, meantime, three control groups were set (pmirGLO vector with mutated
sequence and miR-30a-3p mimic, pmirGLO vector with wild type sequence and mimic NC, pmirGLO
vector with mutated sequence and mimic NC). The results showed that the relative luminescence
activity of the group with a wild-type plasmid and mimic was significantly decreased compared to
the group transfected with mutated plasmid and mimic, and the group with wild type plasmids and
mimic NC (Figure 2F). Moreover, the RNA level of circHIPK3 was significantly down-regulated after
over-expression of miR-30a-3p mimic, compared to the group transfected with mimic NC (Figure 2G).
Subsequently, the result of flow cytometry analysis showed that miR-30a-3p could reverse the effect
of circHIPK3 on a cell cycle (Figure 2H). Altogether, these results indicated that miR-30a-3p could
interact with circHIPK3.
3.3. miR-30a-3p Inhibits Myoblast Proliferation
To explore the function of miR-30a-3p on the proliferation of CPMs, miR-30a-3p mimic and
inhibitor were transfected into CPMs with 100 nM to detect an over-expression effect and an inhibitory
effect. The results showed that the two oligos of miR-30a-3p had the effect as expected compared
with the mimic NC group, and inhibitor NC group, respectively, and could be used in the subsequent
experiments (Figure 3A,B). After being transfected with miR-30a-3p mimic/mimic NC and miR-30a-3p
inhibitor/inhibitor NC, flow cytometry analysis was performed in CPMs and the results showed that
ectopic expression of miR-30a-3p suppressed the cell cycle markedly, while knock-down of miR-30a-3p
significantly promoted the cell cycle (Figure 3C,D). Besides, CCK-8 assay was conducted to detect of
proliferation vitality in CPMs. The results showed that the group which transfected with miR-30a-3p
mimic had a lower proliferation vitality than mimic NC. In contrast, the group which transfected
with miR-30a-3p inhibitor had a higher proliferation vitality than inhibitor NC group (Figure 3E,F).
Furthermore, the EdU assay demonstrated that the rate of the cells, which were in the cell division
in the ectopic expression group, was significantly less than in the mimic NC group, and the statistics
of the cell proliferation rate of the miR-30a-3p over-expression group, were markedly lower than the
control group (Figure 3G). Conversely, knock-down of miR-30a-3p dramatically increased the numbers
of EdU strained cells compare with the inhibitor NC group (Figure 3H). Altogether, these results
indicated that miR-30a-3p could suppress myoblast proliferation.
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3.4. MEF2C Is a Target Gene of miR-30a-3p
To investigate the potential function of miR-30a-3p on CPM differentiation, we try to find
the differentiation-related genes among the targets of miR-30a-3p. Interestingly, there are three
potential binding sites in the 30 UTR region of MEF2C (Figure 4A). The potential interaction model
from RNAhybrid showed that the binding site 3 was the most stable format (Figure 4B). To validate the
target relationship between MEF2C and miR-30a-3p, wild-type and mutated-type sequences containing
three binding sites, separately, were inserted into the pmirGLO vector for construction of pmirGLO
dual-luciferase miRNA target expression vector. After co-transfection of vectors and mimics (or mimic
NC), relative luminescence activities were detected by a Fluorescence/Multi-Detection Microplate
Reader. For the Binding site 1, the relative luminescence activity of the group, with wild type reporter
and mimic, was significantly lower compared with the control groups, which transfected with mutated
reporters and mimic, wild type reporter and mimic NC, separately (Figure 4C). For the Binding site
2 and Binding site 3, the luminescence activity of the groups with wild type plasmids and mimic
were all dramatically lower than the three control groups (mutated reporters and mimic, wild type
reporter and mimic NC, mutated reporters and mimic NC) (Figure 4D,E). Particularly, the binding site
3 exerted the most significant interaction with miR-30a-3p compare with the control groups. The RNA
expression level of MEF2C was significantly decreased after ectopic expression of miR-30a-3p mimic
compared with the group transfected with mimic NC (Figure 4F).
3.5. miR-30a-3p Represses CPM Differentiation
After the confirmation of the target relationship between miR-30a-3p and MEF2C, we try to
investigate the potential role of miR-30a-3p on CPM differentiation. First, the expression profile of
miR-30a-3p was detected in the process of differentiation in CPMs. Interestingly, the expression
level of miR-30a-3p was decreased in the first two days of differentiation medium (DM) compare
to GM (growth medium), then increased in DM3 and DM4 (Figure 5A). Then, the expression of
the myoblast differentiation marker genes, including MYOD, MYOG, and MYHC were evaluated
by qPCR in myoblast transfected with miR-30a-3p mimic (or mimic NC) and inhibitor (or inhibitor
NC). Over-expression of miR-30a-3p notably inhibited the expression of MYOD, MYOG, and MYHC
compared with the groups transfected with mimic NC. Conversely, knock-down of miR-30a-3p
promoted the expression of MYOD, MYOG and MYHC relative to the inhibitor NC group (Figure 5B,C).
The protein level of MYHC was also detected by western blotting. Ectopic expression of miR-30a-3p
inhibited the expression MYHC, conversely, knock-down of miR-30a-3p promoted the protein
expression of MYHC (Figure 5D). MYHC immunofluorescence staining was employed on those
transfected differentiated myoblasts at DM5. The results showed that the total area of myotubes of
miR-30a-3p mimic transfected group was markedly less than that of the group transfected with mimic
NC (Figure 5E). On the contrary, the areas of myotubes in miR-30a-3p inhibitor transfected group was
more than that of control group (Figure 5F). To sum up, these results revealed that miR-30a-3p could
repress CPM differentiation.
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3.6. circHIPK3 Promotes the Proliferation of CPMs
Given that circHIPK3 could act as a sponge of miR-30a-3p, and miR-30a-3p could repress the
proliferation of CPMs, we hypothesized that circHIPK3 played an opposite role on the proliferation of
CPMs. To investigate the role of circHIPK3 on skeletal muscle cell proliferation, the over-expression
vector and siRNAs were transfected into CPMs. The over-expression vectors expressed high levels of
circHIPK3 compared with the group transfected with pCD5ciR (Figure 6A), and all three siRNAs could
significantly knock down the level of circHIPK3 relative to siRNA NC group (Figure 6B). Among the
three siRNAs, si-circHIPK3-003 had the highest efficiency of interference effect and was chosen for
the following experiments. After being transfected with circHIPK3 over-expression vector/pCD5ciR
and si-circHIPK3-003/siRNA NC, flow cytometry analysis in CPMs was performed and the results
showed that ectopic expression of circHIPK3 notably promoted the cell cycle, conversely, knock-down
of circHIPK3 significantly retarded the cell cycle (Figure 6C,D). Moreover, CCK-8 assay was used
to detect the proliferation vitality in CPMs. The results showed that the groups which transfected
with circHIPK3 over-expression vectors, had higher proliferation vitality than the negative control
group. In contrast, the groups which transfected with si-circHIPK3-003, had lower proliferation vitality
than siRNA NC group (Figure 6E,F). The EdU assay indicated that the rate of the cells which were
in the cell division in circHIPK3 over-expression group was significantly more than pCD5ciR group,
the statistics of the cell proliferation rate of the circHIPK3 over-expression group were markedly
higher (Figure 6G). Conversely, knock-down of circHIPK3 decreased the numbers of EdU strained
cells dramatically (Figure 6H). In summary, these results demonstrated that circHIPK3 promoted the
proliferation of CPMs.
3.7. circHIPK3 Promotes the Differentiation of CPMs
As the miR-30a-3p had the effect on CPM differentiation, and miR-30a-3p could interact with
circHIPK3, we speculated that circHIPK3 might have the opposite effect on CPM differentiation.
To confirm our hypothesis, the expression profile of circHIPK3 was detected in the process of
differentiation in CPMs. Interestingly, the expression trend of circHIPK3 coincided with miR-30a-3p,
and it dramatically decreased in the DM phase compare to GM but raised gradually in DM4 (Figure 7A),
indicating that circHIPK3 may be related to the differentiation of CPMs. Then, the expression level
of the myoblast differentiation marker genes including MYOD, MYOG and MYHC were evaluated
by qPCR in CPMs transfected with circHIPK3 over-expression vector/pCD5ciR and siRNA/siRNA
NC. The expression levels of MYOG and MYHC but not MYOD were significantly increased in
CPMs transfected with the over-expression vector compare with the group transfected with pCD5ciR
(Figure 7B). On the contrary, knock-down of circHIPK3 significantly inhibited the expression of MYOD,
MYOG and MYHC compare with the siRNA NC group (Figure 7C). The relative protein level of MYHC
was also decreased after knock-down of circHIPK3 (Figure 7D). Moreover, MYHC immunofluorescence
staining was conducted on transfected differentiated CPMs at DM5. The results showed that the total
area of myotubes of si-circHIPK3-003 transfected group was notably less than that of siRNA NC group,
and the statistics of the myotube area rate of the si-circHIPK3-003 group were markedly lower than
that of siRNA NC group (Figure 7E). These results suggested that circHIPK3 had counteractive effect
of miR-30a-3p on CPM differentiation and knock-down of circHIPK3 suppressed the differentiation
of CPMs.
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3.7. circHIPK3 Promotes the Differentiation of CPMs
As the miR-30a-3p had the effect on CPM differentiation, and miR-30a-3p could interact with
circHIPK3, we speculated that circHIPK3 might have the opposite effect on CPM differentiation. To

MYHC immunofluorescence staining was conducted on transfected differentiated CPMs at DM5. The
results showed that the total area of myotubes of si-circHIPK3-003 transfected group was notably less
than that of siRNA NC group, and the statistics of the myotube area rate of the si-circHIPK3-003
group were markedly lower than that of siRNA NC group (Figure 7E). These results suggested that
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had counteractive effect of miR-30a-3p on CPM differentiation and knock-down
of
circHIPK3 suppressed the differentiation of CPMs.

Figure 7. CircHIPK3 promotes the differentiation of CPMs. (A) The expression profile of circHIPK3 in
the process of CPMs induced differentiation. (B) The expression level of MYOD, MYOG and MYHC
in CPMs after over-expression of circHIPK3. (C) The expression of MYOD, MYOG and MYHC in
CPMs after knock-down of circHIPK3. (D) The protein level of MYHC in CPMs after knock-down of
circHIPK3. (E) Immunofluorescence analysis of MYHC-staining cells after knock-down of circHIPK3
in CPMs, * p < 0.05; ** p < 0.01; *** p < 0.001.

4. Discussion
Recently, circular RNAs have been identified as a new regulatory factor in multiple biological
processes in different kinds of species [18,22–24]. Generally, the expression pattern of circular RNAs
were corresponding to their linear parental transcript, the expression levels of circular RNAs were
lower and had less functions compare to the corresponding mRNA [25,26]. However, some circular
RNAs expressed independently high levels and exerted crucial roles in some special cell lines or
tissues [14,27]. Many studies proved that circular RNAs were differentially expressed in different
muscle developmental stages and played crucial roles in muscle development [28]. Circular RNA
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sequencing analysis, in different kinds of muscle cells or tissues, among many species, showed that
most of the circular RNAs were exonic circular RNAs and differentially expressed during aging [29,30].
Functional circular RNAs in myoblast differentiation play a role by acting as an miRNA sponge or
translating micropeptide [15,29,31,32]. Previous circular RNA sequencing data (GSE89355) showed that
circHIPK3 was differentially expressed in three stages of chicken muscle development and expressed
the highest level, while compared with the other ten circular RNAs, which was produced by chicken
HIPK3. In this study, we found that circHIPK3 maintained a high expression level in myoblast and
decreased sharply from DM1 to DM4, then the expression trend of circHIPK3 increased. This unique
expression pattern suggested that circHIPK3 may have an important impact on CPM proliferation
and differentiation.
MicroRNAs have been found to be widespread in various cell types or tissues and exerted
a regulatory role in biological development [33–35]. It exerted important functions in muscle
development and was associated with phenotypic changes in skeletal muscle [36,37]. miR-30a-3p
is an inhibitor of proliferation in cancer cells [11,12]. In chicken skeletal muscle development,
miR-30a-3p differentially expressed in three stages [38]. In this study, we demonstrated that miR-30a-3p
inhibited the proliferation of CPMs and suppressed the differentiation by inhibiting the expression
of MEF2C. According to the resources of microRNA viewer (http://people.csail.mit.edu/akiezun/
microRNAviewer/index.html) (Supplementary Figure), miR-30a-3p was conserved in multiple species.
The current study provided information to similar studies in other species.
Circular RNA that possesses miRNA response elements (MREs) is known to be a sponge for
miRNAs [39]. Previous studies confirmed that the miR-30a family could bind to circHIPK3 in mice [40].
Given the homology of circHIPK3 and miR-30a family, we found that circHIPK3 possessed three
potential binding sites for miR-30a-3p, through bioinformatic analyses by miRDB and RNAhybrid.
Then two methods were conducted and we confirmed there are interactions between circHIPK3 and
miR-30a-3p. Therefore, we hypothesized that circHIPK3 might play an opposite role of miR-30a-3p on
skeletal muscle development.
CircHIPK3 was found to be involved in cell proliferation by acting as a sponge of multiple
miRNAs, and HIPK3 gene could produce several circular RNAs with different types in previous
study [40,41]. miR-30a inhibited the proliferation by involving in different pathways in different kinds
of cells [11,42,43]. In this study, we found that circHIPK3 promoted the proliferation and differentiation
of CPMs by combing with miR-30a-3p. However, the underlying mechanism of miR-30a-3p retarding
the myoblast proliferation needs further investigation.
In conclusion, our results suggested that miR-30a-3p could inhibit the proliferation of CPMs and
repress the differentiation of CPMs by decreasing the expression of MEF2C, while circHIPK3 could
promote the proliferation and differentiation of CPMs by sponging miR-30a-3p.
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